Reda Keddar is currently a Senior Scientist in Computational Biology at AstraZeneca, where they analyze real-world and cross-trial data to understand mechanisms of resistance to cancer immunotherapy. They previously held the position of Marie Sklodowska-Curie Fellow at both King's College London and The Francis Crick Institute from 2018 to 2022. Reda earned a PhD in Computational Biology and a Master's degree in Computer Science, both from King's College London, and holds an Engineer's degree in Computer Engineering from Ecole nationale Superieure d'Informatique.
Location
Cambridge, United Kingdom